The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net (loss) income | -530,200 | 711,500 | 321,100 | 686,500 |
| Amortization | 410,200 | 405,500 | 402,300 | 405,500 |
| Impairment charges | 785,000 | 0 | 160,800 | - |
| Gain on sale of business | -5,100 | 446,600 | - | - |
| Stock-based compensation expense | 46,400 | 46,800 | 40,500 | 45,800 |
| Non-cash restructuring charges (see note 12) | 3,200 | 16,900 | - | - |
| Provision for accounts receivable and inventory | 63,700 | 75,100 | 84,500 | 65,000 |
| Deferred income tax expense (benefit) | 7,700 | -46,900 | -172,400 | -69,100 |
| Amortization of deferred financing costs | 8,500 | 11,200 | 13,000 | 15,700 |
| Loss on extinguishment of debt | -4,600 | -10,900 | -6,900 | -12,500 |
| Foreign currency remeasurement loss (gain) | -1,700 | 300 | 2,600 | -10,000 |
| Pension termination charges | 18,100 | 9,300 | - | - |
| Accounts receivable | -13,600 | -45,900 | -77,000 | 45,200 |
| Inventory | 109,400 | 18,500 | -30,300 | 112,500 |
| Accounts payable | 42,400 | 59,600 | -139,600 | 15,600 |
| Accrued interest | -1,300 | -1,600 | 300 | 100 |
| Other assets and liabilities | 144,200 | 37,700 | -48,600 | 179,300 |
| Other | 1,300 | 300 | 700 | 7,000 |
| Net cash provided by operating activities | 623,800 | 840,800 | 870,000 | 843,600 |
| Capital expenditures | 128,800 | 148,800 | 146,400 | 133,400 |
| Cash paid for acquisitions, net of cash acquired | - | 0 | 0 | 20,200 |
| Cash proceeds from settlement of cross currency swap | - | 0 | 0 | 42,500 |
| Proceeds from sale of disposal group, net of cash sold | 0 | 585,200 | - | - |
| Other | 1,700 | -2,500 | -2,700 | -1,500 |
| Net cash (used in) provided by investing activities | -130,500 | 438,900 | -143,700 | -109,600 |
| Debt borrowings | 1,107,600 | 0 | 0 | 327,200 |
| Debt repayments | 1,426,300 | 1,341,800 | 846,000 | 947,000 |
| Payments of debt refinancing fees | 15,100 | 0 | 2,300 | 600 |
| Proceeds from issuance of stock, net of issuance costs | - | - | 0 | 0 |
| Payments of dividends on preferred stock | - | 0 | 0 | 32,400 |
| Proceeds received from exercise of stock options | 5,100 | 69,200 | 18,300 | 17,300 |
| Proceeds received from exercise of stock options | 5,600 | - | - | - |
| Proceeds received from exercise of stock options, net of shares repurchased to satisfy employee tax obligations for vested stock-based awards | - | -8,600 | -13,700 | -13,200 |
| Payments for repurchase of common stock | 75,100 | - | - | - |
| Net cash used in financing activities | -409,400 | -1,281,200 | -843,700 | -648,700 |
| Effect of currency rate changes on cash and cash equivalents | 19,700 | -21,500 | 8,200 | -15,500 |
| Net change in cash, cash equivalents and restricted cash | 103,600 | -23,000 | -109,200 | 69,800 |
| Cash and cash equivalents at beginning of period | 264,700 | 287,700 | 396,900 | 327,100 |
| Cash and cash equivalents at end of period | 368,300 | 264,700 | 287,700 | 396,900 |
Avantor, Inc. (AVTR)
Avantor, Inc. (AVTR)